BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30562059)

  • 1. EP
    Higuchi S; Fujikawa R; Nakatsuji M; Yasui M; Ikedo T; Nagata M; Mishima K; Irie K; Matsumoto M; Yokode M; Minami M
    Am J Physiol Endocrinol Metab; 2019 Mar; 316(3):E410-E417. PubMed ID: 30562059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice.
    Zhang Y; Guan Q; Liu Y; Zhang Y; Chen Y; Chen J; Liu Y; Su Z
    J Biol Chem; 2018 May; 293(20):7894-7904. PubMed ID: 29530977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state.
    Foretz M; Hébrard S; Leclerc J; Zarrinpashneh E; Soty M; Mithieux G; Sakamoto K; Andreelli F; Viollet B
    J Clin Invest; 2010 Jul; 120(7):2355-69. PubMed ID: 20577053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perturbation of glucose flux in the liver by decreasing F26P2 levels causes hepatic insulin resistance and hyperglycemia.
    Wu C; Khan SA; Peng LJ; Li H; Carmella SG; Lange AJ
    Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E536-43. PubMed ID: 16621898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation.
    Kim YD; Li T; Ahn SW; Kim DK; Lee JM; Hwang SL; Kim YH; Lee CH; Lee IK; Chiang JY; Choi HS
    J Biol Chem; 2012 Oct; 287(44):37098-108. PubMed ID: 22977252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-IV reduces hepatic gluconeogenesis through nuclear receptor NR1D1.
    Li X; Xu M; Wang F; Kohan AB; Haas MK; Yang Q; Lou D; Obici S; Davidson WS; Tso P
    J Biol Chem; 2014 Jan; 289(4):2396-404. PubMed ID: 24311788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-Inducible SMILE Inhibits Hepatic Gluconeogenesis.
    Lee JM; Seo WY; Han HS; Oh KJ; Lee YS; Kim DK; Choi S; Choi BH; Harris RA; Lee CH; Koo SH; Choi HS
    Diabetes; 2016 Jan; 65(1):62-73. PubMed ID: 26340929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear factor erythroid 2-related factor 2 deletion impairs glucose tolerance and exacerbates hyperglycemia in type 1 diabetic mice.
    Aleksunes LM; Reisman SA; Yeager RL; Goedken MJ; Klaassen CD
    J Pharmacol Exp Ther; 2010 Apr; 333(1):140-51. PubMed ID: 20086057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiopoietin-like protein 8 (betatrophin) inhibits hepatic gluconeogenesis through PI3K/Akt signaling pathway in diabetic mice.
    Zhao Z; Deng X; Jia J; Zhao L; Wang C; Cai Z; Guo C; Yang L; Wang D; Ma S; Deng J; Li H; Zhou L; Tu Z; Yuan G
    Metabolism; 2022 Jan; 126():154921. PubMed ID: 34715116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction.
    Banerjee S; Ghoshal S; Stevens JR; McCommis KS; Gao S; Castro-Sepulveda M; Mizgier ML; Girardet C; Kumar KG; Galgani JE; Niehoff ML; Farr SA; Zhang J; Butler AA
    J Biol Chem; 2020 Oct; 295(40):13753-13768. PubMed ID: 32727846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of hepatic neuregulin 4 in the regulation of gluconeogenesis in mice.
    Zhang L; Bai M; Tang H; Zhou F; Zhu Q; Wang S; Zhu K; Liu Q; Liu Y; Wang X; Ma Y; Zhou L
    Life Sci; 2019 Jan; 217():185-192. PubMed ID: 30528184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone-induced Krüppel-like factor 9 expression promotes hepatic gluconeogenesis and hyperglycemia.
    Cui A; Fan H; Zhang Y; Zhang Y; Niu D; Liu S; Liu Q; Ma W; Shen Z; Shen L; Liu Y; Zhang H; Xue Y; Cui Y; Wang Q; Xiao X; Fang F; Yang J; Cui Q; Chang Y
    J Clin Invest; 2019 Apr; 129(6):2266-2278. PubMed ID: 31033478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The KLF14 transcription factor regulates hepatic gluconeogenesis in mice.
    Wang L; Tong X; Gu F; Zhang L; Chen W; Cheng X; Xie L; Chang Y; Zhang H
    J Biol Chem; 2017 Dec; 292(52):21631-21642. PubMed ID: 29123026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB).
    Xiao F; Deng J; Jiao F; Hu X; Jiang H; Yuan F; Chen S; Niu Y; Jiang X; Guo F
    FASEB J; 2022 Oct; 36(10):e22541. PubMed ID: 36083102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forkhead Box O6 (FoxO6) Depletion Attenuates Hepatic Gluconeogenesis and Protects against Fat-induced Glucose Disorder in Mice.
    Calabuig-Navarro V; Yamauchi J; Lee S; Zhang T; Liu YZ; Sadlek K; Coudriet GM; Piganelli JD; Jiang CL; Miller R; Lowe M; Harashima H; Dong HH
    J Biol Chem; 2015 Jun; 290(25):15581-15594. PubMed ID: 25944898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
    Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
    Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel liver-specific TORC2 siRNA corrects hyperglycemia in rodent models of type 2 diabetes.
    Saberi M; Bjelica D; Schenk S; Imamura T; Bandyopadhyay G; Li P; Jadhar V; Vargeese C; Wang W; Bowman K; Zhang Y; Polisky B; Olefsky JM
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1137-46. PubMed ID: 19706791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.